Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

<p dir="ltr">Triple-negative breast cancer (TNBC) accounts for ~15–20% of breast cancer (BC) and has a higher rate of early relapse and mortality compared to other subtypes. The Chemokine (C-C motif) ligand 5 (CCL5) and its signaling pathway have been linked to TNBC. We aimed to inve...

Full description

Saved in:
Bibliographic Details
Main Author: Jingxuan Shan (4711089) (author)
Other Authors: Aziz Chouchane (8089028) (author), Younes Mokrab (6367) (author), Mohamad Saad (214545) (author), Salha Boujassoum (8089031) (author), Rosalyn W. Sayaman (8089034) (author), Elad Ziv (1263) (author), Noureddine Bouaouina (61837) (author), Yasmine Remadi (8089037) (author), Sallouha Gabbouj (8089040) (author), Jessica Roelands (7516439) (author), Xiaojing Ma (44943) (author), Davide Bedognetti (2632474) (author), Lotfi Chouchane (61840) (author)
Published: 2019
Subjects:
Biomedical and clinical sciences
Oncology and carcinogenesis
CCL5
CCL5 signaling genes
triple negative breast cancer
prognosis
susceptibility
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items